European Journal of Cancer, 182, pp. 132-143 European Journal of Cancer, 182, 132-143. ELSEVIER SCI LTD European Journal of Cancer, 182, 132-143. Pergamon van Breeschoten, J, van den Eertwegh, A J M, Hilarius, D L, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Stevense-den Boer, M A, van der Veldt, A A M, Vreugdenhil, G, Boers-Sonderen, M J, Manevski, D, Suijkerbuijk, K P M, Wouters, M W J M & de Wreede, L C 2023, ' Population mortality in advanced melanoma patients with and without response and progression; data from the Dutch Melanoma Treatment Registry ', European Journal of Cancer, vol. 182, pp. 132-143 . https://doi.org/10.1016/j.ejca.2023.01.006 European Journal of Cancer, 182, 132-143 European Journal of Cancer, 182, 132-143. Elsevier Ltd.
European journal of cancer (Oxford, England : 1990), 167, 70-80. Elsevier Ltd. van Not, O J, de Meza, M M, van den Eertwegh, A J M, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, van Breeschoten, J, de Groot, J-W B, Hospers, G A P, Ismail, R K, Kapiteijn, E, Piersma, D, van Rijn, R S, Stevense-den Boer, M A M, van der Veldt, A A M, Vreugdenhil, G, Bonenkamp, H J, Boers-Sonderen, M J, Blokx, W A M, Wouters, M W J M & Suijkerbuijk, K P M 2022, ' Response to immune checkpoint inhibitors in acral melanoma : A nationwide cohort study ', European Journal of Cancer, vol. 167, pp. 70-80 . https://doi.org/10.1016/j.ejca.2022.02.026 European Journal of Cancer, 167, 70-80. ELSEVIER SCI LTD European Journal of Cancer, 167, pp. 70-80 European Journal of Cancer, 167, 70-80 European Journal of Cancer, 167, 70-80. Pergamon
International Journal of Cancer, 150(5), 816-824. Wiley van Not, O J, van Breeschoten, J, van den Eertwegh, A J M, Hilarius, D L, de Meza, M M, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J W B, Hospers, G A P, Ismail, R K, Kapiteijn, E, Piersma, D, van Rijn, R S, Stevense-den Boer, M A M, van der Veldt, A A M, Vreugdenhil, G, Boers-Sonderen, M J, Blokx, W A M, Suijkerbuijk, K P M & Wouters, M W J M 2022, ' The unfavorable effects of COVID-19 on Dutch advanced melanoma care ', International Journal of Cancer, vol. 150, no. 5, pp. 816-824 . https://doi.org/10.1002/ijc.33833 International Journal of Cancer, 150, 816-824 International Journal of Cancer, 150, 5, pp. 816-824 International Journal of Cancer, 150(5), 816-824. Wiley-Liss Inc. International Journal of Cancer, 150(5), 816-824. WILEY International Journal of Cancer
JCO oncology practice, 18(10):e1611 JCO Oncology Practice, 18(10), e1611-e1620. American Society of Clinical Oncology None JCO oncology practice, 18(10), e1611-e1620. Lippincott Williams and Wilkins Ltd. van Breeschoten, J, Ismail, R K, Wouters, M W J M, Hilarius, D L, de Wreede, L C, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Stevense-den Boer, M A, van der Veldt, A A M, Vreugdenhil, G, Boers-Sonderen, M J, Suijkerbuijk, K P M & van den Eertwegh, A J M 2022, ' End-of-Life Use of Systemic Therapy in Patients With Advanced Melanoma : A Nationwide Cohort Study ', JCO oncology practice, vol. 18, no. 10, pp. e1611-e1620 . https://doi.org/10.1200/OP.22.00061 JCO Oncology Practice, 18, 10, pp. e1611-e1620 JCO Oncology Practice, 18(10), e1611-e1620. LIPPINCOTT WILLIAMS & WILKINS JCO Oncology Practice, 18, e1611-e1620
British Journal of Cancer British Journal of Cancer, 124(7), 1222-1230. Nature Publishing Group British Journal of Cancer, 124, 7, pp. 1222-1230 British Journal of Cancer, 124, 1222-1230 van Breeschoten, J, Wouters, M W J M, Hilarius, D L, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J-W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, Blokx, W A M, Tije, B-J J T, Veldt, A A M V D, Vreugdenhil, A, Boers-Sonderen, M J & van den Eertwegh, A J M 2021, ' First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis ', British Journal of Cancer, vol. 124, no. 7, pp. 1222-1230 . https://doi.org/10.1038/s41416-020-01229-1 British Journal of Cancer, 124(7), 1222-1230. SPRINGERNATURE